®
About Us
Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.
With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.
Qualifications
BD208720[885693-20-9]tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate*
Specific Information
| Purity : | 97% | Specific Rotation : | |
| NMR(H/C/F/S/P) : | E.E. : | ||
| HPLC : | Water Content : | ||
| Polymerization Inhibitor : | Single Impurity : | ||
| Melting Point : | Density : | ||
| Packaging : | Solubility : | ||
| Name Note : | Acetic Acid : | ||
| Beilstein : | Grade : | ||
| Specific Gravity : | Viscosity : | ||
| Others : | |||
Product Details
| Cat No. : | BD208720 | Synonyms : | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate |
| CAS No. : | 885693-20-9 | MDL NO : | MFCD10697911 |
| Formule : | C16H28BNO4 | InChI Key : | N/A |
| M.W : | 309.21 | Pubchem ID : | 49835909 |
| Boiling Point : | |||
Safety
| Signal Word : | Warning | Class : | N/A |
| Precautionary Statements : | P261-P280-P305+P351+P338 | UN# : | N/A |
| Hazard Statements : | H302-H315-H319-H332-H335 | Packing Group : | N/A |
| GHS Pictogram: | |||
R&D Center
- +CONTACT
TM
Copyright © 2013-2024 BLDpharm. All Rights Reserved.
Research Use Only!